(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Trial details
- Registry ID
- NCT05607004
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as endoxifen
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNCT05607004 | ATOS | Phase 2 | Active not recruiting | 2026-11Estimated |
| (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious PubertyNCT07869732 | ATOS | Phase 2 | Not yet recruiting | 2028-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |